Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Athanese Lavidas currently holds 177,881 shares of ARIAD PHARMACEUTICALS INC (ARIA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Athanese Lavidas has been a net seller of ARIA stock. They have purchased $0 and sold $1.9M worth of shares.
Athanese Lavidas's most recent insider trade was on Jun 15, 2016, when they sold 6,250 shares at $4.91 per share.
Athanese Lavidas serves as Executive at ARIAD PHARMACEUTICALS INC (ARIA). They have executed 29 insider transactions totaling $1.9M over their tenure at the company.
Athanese Lavidas holds the position of Executive at ARIAD PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Athanese Lavidas has shown a selling trading pattern, with $0 in total purchases and $1.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Athanese Lavidas was on Jun 5, 2012, when they sold $401.3K worth of ARIA shares. This transaction involved 25,000 shares at $16.05 per share.
Athanese Lavidas currently owns 177,881 shares of ARIAD PHARMACEUTICALS INC (ARIA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Athanese Lavidas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Athanese Lavidas has 29 Form 4 filings on record as an insider at ARIAD PHARMACEUTICALS INC.
Set alerts for Athanese Lavidas and 40,000+ other insiders.